Today: 10 June 2026
BigBear.ai (BBAI) stock in focus before the open as $125 million notes convert — and a dilution vote looms
16 January 2026
1 min read

BigBear.ai (BBAI) stock in focus before the open as $125 million notes convert — and a dilution vote looms

New York, Jan 16, 2026, 09:28 EST — Premarket

  • BigBear.ai shares slipped 1.3% premarket to $6.17 following its latest balance-sheet update
  • Company reports that $125 million of 2029 convertible notes have been completely converted into stock
  • Shareholders will vote on Jan. 22 to approve doubling the authorized shares to 1 billion

Shares of BigBear.ai Holdings, Inc slipped about 1.3% to $6.17 in premarket trading Friday after the company announced the full conversion of $125 million in convertible senior secured notes due 2029 into common stock. The move wiped out roughly $125 million in debt without a significant cash payout. Following the transaction, the company’s note-related debt shrank to around $17 million, linked to convertible notes maturing in December 2026.

Why it matters now: convertible notes are debt that can convert into shares, and that trade-off is out in the open. Cutting debt eases financial pressure, but issuing new stock to cover it risks diluting current shareholders.

The balance-sheet cleanup comes amid a shareholder vote on share capacity. In proxy materials filed Thursday, CFO Sean Ricker said the company is “97% of the way to reaching the required votes” to boost authorized common stock from 500 million to 1 billion shares. The special meeting will reconvene on Jan. 22, with voting open through late Jan. 21, the filing showed. Ricker also pointed to backing from proxy advisers ISS and Glass Lewis. BigBear.ai Holdings, Inc.

Authorized shares set the legal limit on how many shares a company can issue per its charter. Simply increasing that limit doesn’t cause dilution, but it opens the door for the board to issue more stock down the line — whether for acquisitions, employee compensation, or fundraising. Traders usually price in that potential pretty quickly.

Markets held steady before the extended U.S. holiday weekend, with Wall Street closed Monday for Martin Luther King Jr. Day. This can sap liquidity and amplify swings in smaller stocks when trading resumes.

BigBear.ai, headquartered in McLean, Virginia, provides AI software and services for defense, national security, and critical infrastructure sectors. Recently, the company has turned to balance-sheet maneuvers amid investor concerns over financing risks in smaller AI-related firms.

The setup works both ways. Should shareholders greenlight a larger share authorization, investors will be keen to see how fast the company uses that leeway—and on what conditions. If the proposal stalls once more, the limited share pool might restrict future deals or capital actions, particularly with convertible debt lingering until 2026.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
LSEG share price today: London Stock Exchange Group dips after 24/7 Digital Settlement House debut, AWS pact
Previous Story

LSEG share price today: London Stock Exchange Group dips after 24/7 Digital Settlement House debut, AWS pact

Microsoft stock slips as Italy probes Activision game sales and Swiss watchdog eyes Microsoft 365 fees
Next Story

Microsoft stock slips as Italy probes Activision game sales and Swiss watchdog eyes Microsoft 365 fees

Go toTop